483 Response Grifols Therapeutics Nov 2000

Jacqueline Diaz Albert FDA, Mariza Jafary FDA, Robert Jennings FDA$119.00 - Available Now

FDA investigators audited the Grifols Therapeutics - Clayton, NC, United States facility and issued inspectional observation (via FDA 483) on 17 Nov 2000.

Product details

  • Category:
  • Inspection end: 17 Nov 2000
  • Location: Clayton, United States
  • FEI: 1050373
Add To Cart